Get the Stockscreener App
144.47
0.62%
0.89
After Hours:
144.70
0.23
+0.16%
Overview
News
Price History
Option Chain
Financials
Why JNJ Down?
Discussions
Forecast
Stock Split
Dividend History
Johnson Johnson stock is traded at $144.47, with a volume of 13.17M.
It is up +0.62% in the last 24 hours and down -5.64% over the past month.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
See More
Previous Close:
$143.58
Open:
$143.05
24h Volume:
13.17M
Relative Volume:
1.99
Market Cap:
$347.83B
Revenue:
$87.70B
Net Income/Loss:
$14.68B
P/E Ratio:
10.73
EPS:
13.47
Net Cash Flow:
$19.03B
1W Performance:
-1.47%
1M Performance:
-5.64%
6M Performance:
-2.24%
1Y Performance:
-5.74%
1-Day Range:
$142.75
$145.47
1-Week Range:
$142.75
$147.25
52-Week Range:
$142.75
$168.85
Johnson Johnson Stock (JNJ) Company Profile
Name
Johnson Johnson
Sector
Industry
Phone
732-524-2455
Address
ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ
Compare JNJ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
JNJ
Johnson Johnson
|
144.47 | 347.83B | 87.70B | 14.68B | 19.03B | 6.05 |
|
LLY
Lilly Eli Co
|
767.76 | 690.46B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
85.00 | 377.54B | 39.36B | 13.79B | 9.83B | 3.086 |
|
ABBV
Abbvie Inc
|
175.58 | 310.27B | 55.53B | 5.12B | 15.62B | 2.88 |
|
MRK
Merck Co Inc
|
98.05 | 248.03B | 63.17B | 12.15B | 14.84B | 4.77 |
Johnson Johnson Stock (JNJ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-24 | Resumed | BofA Securities | Neutral |
| Nov-15-24 | Initiated | Wolfe Research | Outperform |
| Jul-23-24 | Downgrade | Daiwa Securities | Outperform → Neutral |
| May-30-24 | Resumed | Goldman | Neutral |
| Apr-18-24 | Upgrade | HSBC Securities | Hold → Buy |
| Dec-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-01-23 | Upgrade | UBS | Neutral → Buy |
| Oct-05-23 | Initiated | RBC Capital Mkts | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Resumed | Citigroup | Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Mar-01-23 | Initiated | Guggenheim | Neutral |
| Nov-18-22 | Initiated | Credit Suisse | Neutral |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-14-22 | Reiterated | BofA Securities | Neutral |
| Jun-22-22 | Initiated | Daiwa Securities | Outperform |
| May-23-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-16-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-17-21 | Initiated | Goldman | Neutral |
| Dec-15-21 | Reiterated | Citigroup | Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-28-21 | Resumed | Morgan Stanley | Overweight |
| Apr-28-20 | Downgrade | UBS | Buy → Neutral |
| Apr-22-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Dec-19-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-17-19 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-20-19 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-16-19 | Upgrade | Atlantic Equities | Underweight → Neutral |
| Oct-11-19 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jul-12-19 | Resumed | Credit Suisse | Outperform |
| May-28-19 | Initiated | Goldman | Buy |
| Jan-23-19 | Reiterated | Barclays | Equal Weight |
| Jul-12-18 | Upgrade | Goldman | Sell → Neutral |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-23-18 | Reiterated | Citigroup | Neutral |
| Apr-18-18 | Reiterated | Stifel | Hold |
| Jan-24-18 | Reiterated | Stifel | Hold |
| Jan-12-18 | Reiterated | Wells Fargo | Outperform |
| Jan-02-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-18-17 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-18-17 | Reiterated | Stifel | Hold |
View All
Johnson Johnson Stock (JNJ) Latest News
Senate passes bill to avert government shutdown, sending it to Biden's desk for signature - CBS News
Government shutdown is averted just after deadline as Congress rejects Trump's debt limit demands - The Associated Press
Chaotic scramble to avert shutdown highlights challenges ahead for Johnson - CNN
What we’re watching: Trump and Johnson stare down a shutdown - POLITICO
BLADES STRIKE EARLY AND JOHNSON CLAIMS 100th ECHL WIN - Florida Everblades
Baltimore Ravens waive WR Diontae Johnson after four games, suspension - USA TODAY
Trump-backed bill to keep US government running fails to pass - BBC.com
House approves funding bill and sends to Senate hours before government shutdown deadline - WHYY
WATCH: House approves funding bill, sends to Senate hours before shutdown deadline - PBS NewsHour
Ravens release Diontae Johnson weeks after suspending WR for refusing to enter game vs. Eagles - CBS Sports
Doc Rivers, Marques Johnson and Jon McGlocklin nominees for Naismith Basketball Hall of Fame - Milwaukee Journal Sentinel
Johnson Controls and the City of Toledo: Working towards a smarter future - Johnson Controls
Ravens Waive Diontae Johnson - BaltimoreRavens.com
Baltimore Ravens waive Diontae Johnson - Ravens Wire
Dr. David Barton Johnson ObituaryVisitation & Funeral Information - Heritage Funeral & Cremation Services
Minnesota House tie in peril after judge rules DFL lawmaker can’t be sworn in - MPR News
Is Johnson & Johnson (JNJ) a Cheap NYSE Stock to Invest in Now? - Yahoo Finance
Kentrell Lasavean Ali Johnson Obituary 2024 - Flanner Buchanan
Republicans win MN House majority, for now, after judge rules candidate ineligible - Minnesota Reformer
Musk flexes influence over Congress in shutdown drama - BBC.com
Johnson reengages with Dems after failed Plan B - Axios
Out routes: Ravens waive D. Johnson, sit Agholor - ESPN
Dakota Johnson and Josh Hartnett Join Anne Hathaway in Adaptation of Colleen Hoover’s ‘Verity’ - Hollywood Reporter
Dakota Johnson and Josh Hartnett Join Anne Hathaway in Colleen Hoover’s ‘Verity’ Movie Adaptation - Variety
Colleen Hoover’s ‘Verity’ Adaptation At Amazon MGM Studios Taps Dakota Johnson And Josh Hartnett To Co-Star Opposite Anne Hathaway - Deadline
US House Speaker Mike Johnson's future hangs in balance as he scrambles for funding deal - Reuters.com
‘We’ve got a plan’: Mike Johnson on spending bill - CNN
House rejects Trump-backed plan on government shutdown, leaving next steps uncertain - The Associated Press
Johnson says he has plan C to avert shutdown, vote expected - The Hill
Congress in disarray and shutdown looms as Trump, Musk pan spending deal - BBC.com
Trump and Johnson weigh the pros and cons of a shutdown - POLITICO
Playbook: Do Trump and Johnson want a shutdown? - POLITICO
24 hours that exposed a schism between Trump and Johnson and sent the government hurtling toward a shutdown - CNN
MAGA rebels kill Johnson and Trump's Plan B - Axios
Australian law firm files class action against Johnson & Johnson over 'ineffective' cold and flu medication - ABC News
Johnson Johnson Stock (JNJ) Financials Data
Revenue
Net Income
Cash Flow
EPS
17.83%
2.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):